CD209 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD209 Antibodies for investigating CD209 protein function. CD209 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD209, also known as DC-SIGN, is a C-type lectin receptor primarily expressed on dendritic cells and plays a crucial role in the immune response by mediating the recognition and uptake of pathogens. CD209's ability to bind to various viruses and bacteria makes it an important target for studying infectious diseases and immune regulation. Understanding CD209 function is vital for developing therapeutic strategies against viral infections and enhancing vaccine efficacy. CD209 research has revealed significant insights into pathogen recognition mechanisms and cellular signaling pathways. Ongoing studies continue to uncover new aspects of CD209's role in immune system regulation and disease progression. Research utilizing CD209 monoclonal antibodies has advanced our understanding of dendritic cell function and pathogen interactions. Santa Cruz Biotechnology monoclonal antibodies for CD209 enable researchers worldwide to make meaningful contributions to immunology and infectious disease research.